Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial (Q57752107)
article
Language:
Current Data About Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
(P31) (Q13442814)

(P50) (Q47262835)
(P1545) 7
(P1932) Désirée van der Heijde

(Q91720749)
(P1545) 1
(P1932) Stanley B. Cohen

(P304) 1299-1309

(P407) (Q1860)

(P433) 5

(P478) 58

(P577) +2008-00-00T00:00:00Z

(P921) (Q101929)

(Q327657)

(Q269829)
(P887)

(Q6934595)
(P887)

(Q42824440)
(P887)

(Q187255)
(P887)

(P1433) (Q23929027)

(P1476) "Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial" (language: en)

(P2093) Robin K. Dore
(P1545) 2

Nancy E. Lane
(P1545) 3

Peter A. Ory
(P1545) 4

Charles G. Peterfy
(P1545) 5

John T. Sharp
(P1545) 6

Lifen Zhou
(P1545) 8

Wayne Tsuji
(P1545) 9

Richard Newmark
(P1545) 10

(P2860) (Q41753607)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FART.23417
(P813) Sunday, January 21, 2018

(Q35789185)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FART.23417
(P813) Sunday, January 21, 2018

other details
description article

External Links
(P356) 10.1002/ART.23417
(P698) 18438830